Skip to main content
Clinical Trials/CTRI/2017/05/008635
CTRI/2017/05/008635
Completed
未知

Evaluation of dermatological safety of investigational products by primary irritation patch test on healthy human volunteers of varied skin types. - NI

ITC Life Sciences Technology Centre0 sites24 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
ITC Life Sciences Technology Centre
Enrollment
24
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
ITC Life Sciences Technology Centre

Eligibility Criteria

Inclusion Criteria

  • 1\) Subjects in age group 18 \- 55 years (both the ages inclusive).
  • 2\) Healthy male \& female subjects.
  • 3\) Subjects with Fitzpatrick skin type III to V.
  • 4\) Subjects willing to give a voluntary written informed consent.
  • 5\) Subjects willing to maintain the patch test in position for 24 hours.
  • 6\) Subject having not participated in a similar investigation in the past two weeks.
  • 7\) Subjects willing to come for regular follow up visits.
  • 8\) Subjects ready to follow instructions during the study period.

Exclusion Criteria

  • 1\) Infection, allergy on the tested area.
  • 2\)Skin allergy, antecedents or atopic subjects.
  • 3\) Athletes and subjects with history of excessive sweating.
  • 4\) Cutaneous disease which may influence the study result.
  • 5\) Subjects on oral corticosteroid.
  • 6\) Subjects participating in any other cosmetic or therapeutic trial.
  • 7\) Any history of underlying uncontrolled medical illness including diabetes, liver disease or history of alcoholism, HIV or any other serious medical illness.

Outcomes

Primary Outcomes

Not specified

Similar Trials